Table 1 Demographic, clinical, and spectroscopic data of the studied groups
From: Value of magnetic resonance spectroscopy in geriatric patients with cognitive impairment
|
I No. 20 |
II No. 23 |
III No. 15 |
IV No.15 | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age in years | 0.074 | |||||||||
| Mean ± SD | 67.5 ± 4.3 | 64.9 ± 3.1 | 64.3 ± 3.7 | 64.4 ± 3.2 | ||||||
| Male | No. | 9 | 13 | 7 | 9 | 0.233 | ||||
| % | 45 | 56.5 | 46.7 | 60 | ||||||
| Female | No. | 11 | 10 | 8 | 6 | |||||
| % | 55 | 43.5 | 53.3 | 40 | ||||||
| Hippo NAA |
I vs II P = 0.000 |
I vs IV P = 0.000 |
II vs III P = 0.000 |
III vs IV P = 0.000 | ||||||
| Mean ± SD | 6.7 ± 1 | 10.6 ± 0.5 | 7.5 ± 1.5 | 10.9 ± 0.8 | ||||||
| Hippo Cr. | ||||||||||
| Mean ± SD | 5.1 ± 0.4 | 4.9 ± 0.2 | 4.8 ± 0.2 | 4.9 ± 0.2 | ||||||
| Hippo NAA/Cr |
I vs II P = 0.000 |
I vs IV P = 0.000 |
II vs III P = 0.000 |
III vs IV P = 0.000 | ||||||
| Mean ± SD | 1.3 ± 0.2 | 2.1 ± 0.1 | 1.5 ± 0.2 | 2.2 ± 0.1 | ||||||
| Frontal NAA |
I vs III P = 0.000 |
I vs IV P = 0.000 |
II vs IV P = 0.000 |
III vs IV P = 0.011 | ||||||
| Mean ± SD | 7.7 ± 1.4 | 8.4 ± 1.6 | 9.7 ± 1.3 | 11.4 ± 0.6 | ||||||
| Frontal Cr. | ||||||||||
| Mean ± SD | 4.9 ± 0.2 | 5.1 ± 0.4 | 4.9 ± 0.2 | 4.8 ± 0.2 | ||||||
| Frontal NAA/Cr |
I vs III P = 0.000 |
I vs IV P = 0.000 |
II vs III P = 0.002 |
II vs IV P = 0.000 |
III vs IV P = 0.002 | |||||
| Mean ± SD | 1.6 ± 0.3 | 1.7 ± 0.3 | 1.9 ± 0.3 | 2.4 ± 0.2 | ||||||
| GDS |
I vs II P = 0.000 |
II vs III P = 0.000 |
II vs IV P = 0.000 | |||||||
| Mean ± SD | 3.1 ± 1.4 | 10.3 ± 2.5 | 2.1 ± 1 | 1.7 ± 0.7 | ||||||
| MoCA |
I vs II P = 0.000 |
I vs III P = 0.000 |
I vs IV P = 0.000 |
II vs IV P = 0.000 |
III vs IV P = 0.000 | |||||
| Mean ±SD | 8.6 ± 4.6 | 20.3 ± 2 | 22.7 ± 2.4 | 27.9 ± 1 | ||||||